L-Tryptophan Medium Additive for Sustained Pluripotent Stem Cell Growth
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing media for culturing pluripotent stem cells are inefficient and costly due to rapid depletion of L-tryptophan, an essential amino acid, limiting cell proliferation and requiring large volumes of medium for mass production.
Innovation Solution
Incorporating L-tryptophan or its derivatives at concentrations above 176 μM in the culture medium, particularly in serum-free conditions, to maintain a high proliferation rate and prevent depletion during cell culture.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional media with standard L-tryptophan concentration (44 μM) are used for pluripotent stem cell culture, then the medium composition follows blood-based standards, but L-tryptophan depletes rapidly and becomes a limiting factor for cell proliferation
Solution Approach 1:
The patent applies parameter changes by increasing the L-tryptophan concentration from the conventional 44 μM (blood-based standard) to 176 μM or higher in the culture medium. This parameter modification prevents rapid depletion and maintains adequate L-tryptophan levels throughout the culture period, thereby supporting sustained pluripotent stem cell proliferation without the limiting effects observed in conventional media.
2Quantity of substance
If large volumes of medium are used to culture large amounts of pluripotent stem cells, then sufficient nutrients are available, but the cost of medium reaches about USD 100,000 per patient
Solution Approach 1:
The patent modifies the medium composition by incorporating elevated L-tryptophan concentrations (176 μM or higher), which enhances the nutrient density and supportive capacity of the medium. This allows for more efficient cell proliferation per unit volume, reducing the total medium volume required for large-scale cell production and thereby lowering the overall cost despite maintaining high cell output.
3Productivity
If L-tryptophan concentration is increased to 176 μM or higher, then cell proliferation efficiency improves, but the deviation from blood-based amino acid composition increases
Solution Approach 1:
The patent applies local quality by selectively modifying only the L-tryptophan concentration in the medium while maintaining other amino acid levels according to blood-based standards. This targeted adjustment ensures that the specific nutrient (L-tryptophan) limiting cell proliferation is optimized without unnecessarily altering the overall amino acid profile, thus balancing improved productivity with compositional stability.
Data Source
AI summary
A medium for culturing a pluripotent stem cell, a pluripotent stem cell culture preparation, and a method for culturing a pluripotent stem cell, and a medium additive for promoting proliferation of a pluripotent stem cell. The medium includes L-tryptophan or a dipeptide in which L-tryptophan and an amino acid are peptide-bonded at a concentration of not less than 176 μM. The dipeptide may include L-alanyl-L-tryptophan.